[HTML] WT1 peptide vaccine in Montanide in contrast to poly ICLC, is able to induce WT1-specific immune response with TCR clonal enrichment in myeloid leukemia
H Liu, Y Zha, N Choudhury… - Experimental …, 2018 - ehoonline.biomedcentral.com
The optimal strategy for vaccination to induce CD8+ T cell responses against WT1 is not
known. A pilot randomized study in HLA-A02+ patients to receive vaccination with WT1 in
Montanide or in poly ICLC, a TLR3 agonist, to explore the novel immune adjuvant was …
known. A pilot randomized study in HLA-A02+ patients to receive vaccination with WT1 in
Montanide or in poly ICLC, a TLR3 agonist, to explore the novel immune adjuvant was …
For custom peptides, please visit www.pepmic.com. Our peptide services including but not limited to:
*Peptide Synthesis: From short peptides to long peptides, linear peptides to cyclic peptides.
*Peptide Modifications: Peptide-protein conjugation, D-amino acid peptides, isotope peptides, fluorescent peptides, multiple antigen peptides, multiple disulfide bridge peptides, phosphopeptides etc.
*Catalog Peptides: ACE Inhibitors, Amyloids & Related Peptides, Antimicrobial Peptides, Apelin Peptides, Myelin Oligodendrocyte Glycoprotein (MOG) Peptides, TAT Proteins etc.
*Peptide Salt: TFA, Desalt, Acetate, HCl.
*Peptide Purity: From crude to ＞99.5%.
*Production Capacity: From mg to kg, with a capacity of synthesizing 15,000 peptides/month.
*Peptide Library Synthesis: Alanine Scan, Overlapping, Positional Scan, T-cell Truncated, Scrambled ect.
Quick Links:
Contact Information:
Eva He
eva@pepmic.com
Pepmic Co., Ltdeva@pepmic.com
www.pepmic.com
没有评论:
发表评论